Home » Tenders » Americas » USA » Dxc Toolbox Pharma Edition Software License (Ambis 2212050) Tender, USA - 97377569

Dxc Toolbox Pharma Edition Software License (Ambis 2212050) Tender, USA - 97377569

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Dxc Toolbox Pharma Edition Software License (Ambis 2212050). The project location is USA and the tender is closing on 04 Mar 2024. The tender notice number is NOI-NIAID-24-2212050, while the TOT Ref Number is 97377569. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Dxc Toolbox Pharma Edition Software License (Ambis 2212050)

Deadline : 04 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 97377569

Document Ref. No. : NOI-NIAID-24-2212050

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with DXC Technology Company, 20408 Bashan Drive, Suite 231, Ashburn, VA 20147-5552, to procure a DXC Toolbox Pharma Software.

This is a new purchase of a DXC Toolbox Pharma software that will be used to replace the current software that is no longer accessible to NIAID in the Office of Cyber Infrastructure and Computational Biology (OCICB), Clinical Informatics Branch (CIB).

This requirement is for the purchase of DXC ToolBox Pharma Edition software. The current PDF verification tool utilized for electronic Common Technical Document (eCTD) submissions is Calyx SmartDesk for PDF. However, our perpetual license would no longer have access to the Calyx support team or any future updates/upgrades to the application after December 31st, 2023. Upon evaluating alternative options, it was determined that DXC Toolbox Pharma Edition is the only standalone software available that meets and exceeds the functional requirements for Investigational New Drug (IND) and Drug Master File (DMF) eCTD submissions. DXC Toolbox Pharma Edition software helps develop, modify, and validate documents, create bookmarks and hyperlinks, report metrics, and perform other PDF transformation operations. The tool is used to perform bulk Quality Control (QC) reviews and editing of PDF files from DXC Technology to support the eCTD submissions of IND and DMF studies to the Food and Drug Administration (FDA). The tool will enable the NIAID research divisions, primarily the Division of AIDS (DAIDS) and the Vaccine Research Center (VRC), to continue to meet the regulatory compliance requirement from the FDA to perform the QC review activities on all documentation compiled in support of FDA eCTD submissions. Also, the software has key feature...
Active Contract Opportunity Notice ID NOI-NIAID-24-2212050 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Feb 21, 2024 07:22 am EST
Original Response Date: Mar 04, 2024 11:00 am EST
Inactive Policy: 15 days after response date
Original Inactive Date: Mar 19, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 7A21 - IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE)
NAICS Code: 513210 - Software Publishers

Place of Performance: Rockville, MD 20852 USA